🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this extension study was to establish efficacy and safety of...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2020-04-08
Trial ID
NCT04210843
Treatments Being Tested
This study assessed the effect on asthma control of different dose levels a...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12
Trial ID
NCT01716754
Treatments Being Tested
This was a 52-week, Phase 3 multi-center, randomized, double-blind and plac...
Status
Terminated
Location
Allervie Clinical Research
Start Date
2021-12-07
Trial ID
NCT04984876
Treatments Being Tested
The purpose of this study was to establish safety and efficacy of ligelizum...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-10-17
Trial ID
NCT03580369
Treatments Being Tested
Global Cohort Managed Access Program (MAP) to provide access to ligelizumab...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04903613
Treatments Being Tested
This study will assess the clinical potency of several exposure levels of Q...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01451450
The purpose of this study was to establish efficacy and safety of ligelizum...
Status
Completed
Location
Allervie Clinical Research
Start Date
2018-10-20
Trial ID
NCT03580356
Treatments Being Tested
The purpose of this study was to evaluate the safety and efficacy of ligeli...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-04-13
Trial ID
NCT03907878
Treatments Being Tested
This study will evaluate the safety, tolerability, pharmacokinetics, pharma...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-03
Trial ID
NCT01596712
To evaluate the safety and efficacy of QGE031 versus placebo in patients wi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-01
Trial ID
NCT01688882